News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke Todd Neale September 30, 2025
News Conference News ESC 2025 Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support Todd Neale August 30, 2025
News Conference News ESC 2025 Boosting Potassium Helps Patients at High Risk for Ventricular Arrhythmias Todd Neale August 29, 2025
News Daily News Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients Michael O'Riordan June 16, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Features GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix? Todd Neale November 13, 2024
News Conference News HFSA 2024 FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone? Michael O'Riordan October 02, 2024
News Conference News ESC 2024 Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER Todd Neale August 31, 2024
News Daily News Acute HF Patients Live Longer When Seen by Specialists Michael O'Riordan August 09, 2024
News Conference News AHA 2023 Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3 Shelley Wood November 11, 2023
News Conference News ESC 2023 Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF Todd Neale September 01, 2023
News Conference News ESC 2023 IV Iron in HF Misses (Again) in HEART-FID, but Meta-analysis Sees a Role Shelley Wood August 26, 2023